Multiple Peer-Reviewed Studies Show Prolacta’s 100% Human Milk-Based Nutritional Fortifiers Reduce Risk of Life-Threatening Comorbidities in Premature Infants, Compared to Cow Milk-Based Nutrition

An Exclusive Human Milk Diet with Prolacta's Fortifiers Reduces Risk of BPD, Late-Onset Sepsis, NEC, and ROP While Improving Neurological Development, Clinical Data Demonstrate DUARTE, Calif., July 27, 2022 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of...

Click to view original post